Subscribe
shutterstock_1932588389_marvent
marvent / Shutterstock.com
15 November 2022FeaturesBiotechnologyJanine Swarbrick and Sofie McPherson

Promoting women in STEM

Historically, professions in science and law have been dominated by men, but how does this industry look in 2022? Are women really at the heart of it? Why should they be there? And what more could be done to support women in their careers in this field?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.

More features

Sanofi subsidiary fends off $450m trade secrets case
Pfizer infringed haemophilia therapy patent, says court
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
10x Genomics counsel: ‘Winning cases is a top priority’
HR, lobbying and business strategy…all in a day’s work for today’s counsel
LSPN Fall: Gilead GC shares top drafting tips
LSPN Fall: Why Big Pharma is facing 'a balancing act'
How post-filing data rescued Novo Nordisk’s Ozempic patent in China